Literature DB >> 7577414

Nephrotic syndrome related to systemic lupus erythematosus after griseofulvin therapy.

M Bonilla-Felix1, R Verani, L G Vanasse, A Hebert.   

Abstract

We report a 16-year-old male who developed nephrotic syndrome related to membranous glomerulopathy with clinical and serological evidence of systemic lupus erythematosus after treatment with griseofulvin. To our knowledge, this is the first case of griseofulvin-exacerbated lupus in which nephrotic syndrome has been observed.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7577414     DOI： 10.1007/BF00866733

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


  7 in total

1.  Lupus erythematosus in two patients after griseofulvin treatment of Trichophyton rubrum infection.

Authors:  S ALEXANDER
Journal:  Br J Dermatol       Date:  1962-02       Impact factor: 9.302

2.  Adverse reactions to griseofulvin in patients with circulating anti-SSA/Ro and SSB/La autoantibodies.

Authors:  S Miyagawa; K Sakamoto
Journal:  Am J Med       Date:  1989-07       Impact factor: 4.965

3.  Subacute cutaneous lupus erythematosus lesions precipitated by griseofulvin.

Authors:  S Miyagawa; T Okuchi; Y Shiomi; K Sakamoto
Journal:  J Am Acad Dermatol       Date:  1989-08       Impact factor: 11.527

4.  Griseofulvin and lupus erythematosus.

Authors:  W A Anderson; D Torre
Journal:  J Med Soc N J       Date:  1966-05

5.  Fatal exacerbation of systemic lupus erythematosus after treatment with griseofulvin.

Authors:  R Madhok; A Zoma; H Capell
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-27

6.  Lupus erythematosus exacerbated by griseofulvin.

Authors:  M S Watsky; Y L Lynfield
Journal:  Cutis       Date:  1976-02

7.  Widespread dermatophyte infections that mimic collagen vascular disease.

Authors:  L Almeida; M Grossman
Journal:  J Am Acad Dermatol       Date:  1990-11       Impact factor: 11.527
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.